Richard N Fedorak
Richard N Fedorak
Bestätigte E-Mail-Adresse bei ualberta.ca
TitelZitiert vonJahr
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands, FH Anderson, CN Bernstein, WY Chey, BG Feagan, ...
New England Journal of Medicine 350 (9), 876-885, 2004
20342004
Human anti–tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I Trial
SB Hanauer, WJ Sandborn, P Rutgeerts, RN Fedorak, M Lukas, ...
Gastroenterology 130 (2), 323-333, 2006
15102006
Methotrexate for the treatment of Crohn's disease
BG Feagan, J Rochon, RN Fedorak, EJ Irvine, G Wild, L Sutherland, ...
New England Journal of Medicine 332 (5), 292-297, 1995
9951995
Vedolizumab as induction and maintenance therapy for Crohn's disease
WJ Sandborn, BG Feagan, P Rutgeerts, S Hanauer, JF Colombel, ...
New England Journal of Medicine 369 (8), 711-721, 2013
9882013
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial
WJ Sandborn, SB Hanauer, PJ Rutgeerts, RN Fedorak, M Lukas, ...
Gut, 2007
9462007
Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice
KL Madsen, JS Doyle, LD Jewell, MM Tavernini, RN Fedorak
Gastroenterology 116 (5), 1107-1114, 1999
8531999
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease
BG Feagan, RN Fedorak, EJ Irvine, G Wild, L Sutherland, AH Steinhart, ...
New England Journal of Medicine 342 (22), 1627-1632, 2000
7872000
VSL# 3 probiotic-mixture induces remission in patients with active ulcerative colitis
R Bibiloni, RN Fedorak, GW Tannock, KL Madsen, P Gionchetti, ...
The American journal of gastroenterology 100 (7), 1539, 2005
7482005
Treatment of ulcerative colitis with a humanized antibody to the α4β7 integrin
BG Feagan, GR Greenberg, G Wild, RN Fedorak, P Paré, JWD McDonald, ...
New England Journal of Medicine 352 (24), 2499-2507, 2005
6692005
Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease
EJ Irvine, B Feagan, J Rochon, A Archambault, RN Fedorak, A Groll, ...
Gastroenterology 106 (2), 287-296, 1994
6531994
A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn’s disease
S Schreiber, P Rutgeerts, RN Fedorak, M Khaliq–Kareemi, MA Kamm, ...
Gastroenterology 129 (3), 807-818, 2005
6142005
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
WJ Sandborn, BG Feagan, RN Fedorak, E Scherl, MR Fleisher, S Katz, ...
Gastroenterology 135 (4), 1130-1141, 2008
5922008
The epidemiology of inflammatory bowel disease in Canada: a population-based study
CN Bernstein, A Wajda, LW Svenson, A MacKenzie, M Koehoorn, ...
The American journal of gastroenterology 101 (7), 1559, 2006
5892006
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
W Reinisch, WJ Sandborn, DW Hommes, G D'haens, S Hanauer, ...
Gut 60 (6), 780-787, 2011
5842011
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease
RN Fedorak, A Gangl, CO Elson, P Rutgeerts, S Schreiber, G Wild, ...
Gastroenterology 119 (6), 1473-1482, 2000
5472000
Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group
SJ Van Deventer, CO Elson, RN Fedorak
Gastroenterology 113 (2), 383-389, 1997
5411997
Natalizumab for the treatment of active Crohn’s disease: results of the ENCORE Trial
SR Targan, BG Feagan, RN Fedorak, BA Lashner, R Panaccione, ...
Gastroenterology 132 (5), 1672-1683, 2007
5382007
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
S Schreiber, RN Fedorak, OH Nielsen, G Wild, CN Williams, S Nikolaus, ...
Gastroenterology 119 (6), 1461-1472, 2000
5012000
Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora
KL Madsen, D Malfair, D Gray, JS Doyle, LD Jewell, RN Fedorak
Inflammatory bowel diseases 5 (4), 262-270, 1999
2911999
Low-dose cyclosporine for the treatment of Crohn's disease
BG Feagan, J McDonald, J Rochon, A Laupacis, RN Fedorak, D Kinnear, ...
New England Journal of Medicine 330 (26), 1846-1851, 1994
2751994
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20